Evidence map›Paper›PMID 35238641›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2022

Disruption of the circadian clock component BMAL1 elicits an endocrine adaption impacting on insulin sensitivity and liver disease.

Céline Jouffe, Benjamin D Weger, Eva Martin, Florian Atger, Meltem Weger, Cédric Gobet, Divya Ramnath, Aline Charpagne, Delphine Morin-Rivron, Elizabeth E Powell and 4 more

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 65 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed, 1 pooled it
8.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

65 citing papers in PubMed, 1 synthesis or guideline pooled it, 87 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. The circadian clock controls hepatic stellate cell activation via a BMAL1/CK1ε/REV-ERBα/transgelin signaling pathway.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Artificial light at night (ALAN) negatively affects expression of transcripts involved in biosynthesis of molting and juvenile hormones in Bombyx mori.Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology · 2026
    Article
  13. Article
  14. Review
  15. Circadian clock and cancer.Military Medical Research · 2026
    Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 3 countries.

Céline JouffeNestlé Research, Société des Produits Nestlé, CH-1015 Lausanne, Switzerland.ORCID 0000-0002-7176-4724
Benjamin D WegerNestlé Research, Société des Produits Nestlé, CH-1015 Lausanne, Switzerland.ORCID 0000-0002-1831-3561
Eva MartinNestlé Research, Société des Produits Nestlé, CH-1015 Lausanne, Switzerland.
Florian AtgerNestlé Research, Société des Produits Nestlé, CH-1015 Lausanne, Switzerland.ORCID 0000-0002-6497-0650
Meltem WegerInstitute for Molecular Bioscience, The University of Queensland, St. Lucia QLD 4072, Australia.ORCID 0000-0002-9452-2373
Cédric GobetNestlé Research, Société des Produits Nestlé, CH-1015 Lausanne, Switzerland.ORCID 0000-0001-5627-3444
Divya RamnathInstitute for Molecular Bioscience, The University of Queensland, St. Lucia QLD 4072, Australia.ORCID 0000-0002-1935-9043
Aline CharpagneNestlé Research, Société des Produits Nestlé, CH-1015 Lausanne, Switzerland.
Delphine Morin-RivronNestlé Research, Société des Produits Nestlé, CH-1015 Lausanne, Switzerland.ORCID 0000-0002-9168-3163
Elizabeth E PowellDepartment of Gastroenterology and Hepatology, Princess Alexandra Hospital, Brisbane QLD 4102, Australia.
Matthew J SweetInstitute for Molecular Bioscience, The University of Queensland, St. Lucia QLD 4072, Australia.ORCID 0000-0002-0406-8139
Mojgan MasoodiNestlé Research, Société des Produits Nestlé, CH-1015 Lausanne, Switzerland.ORCID 0000-0001-9840-1731
N Henriette UhlenhautHelmholtz Diabetes Center, Helmholtz Zentrum München, DE-85764 Neuherberg, Germany.ORCID 0000-0002-4220-4779
Frédéric GachonNestlé Research, Société des Produits Nestlé, CH-1015 Lausanne, Switzerland.ORCID 0000-0002-9279-9707
Nestlé (Switzerland) · CHThe University of Queensland · AUHelmholtz Zentrum München · DETranslational Research Institute · AUUniversity Hospital of Bern · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

SignificanceWhile increasing evidence associates the disruption of circadian rhythms with pathologic conditions, including obesity, type 2 diabetes, and nonalcoholic fatty liver diseases (NAFLD), the involved mechanisms are still poorly described. Here, we show that, in both humans and mice, the pathogenesis of NAFLD is associated with the disruption of the circadian clock combined with perturbations of the growth hormone and sex hormone pathways. However, while this condition protects mice from the development of fibrosis and insulin resistance, it correlates with increased fibrosis in humans. This suggests that the perturbation of the circadian clock and its associated disruption of the growth hormone and sex hormone pathways are critical for the pathogenesis of metabolic and liver diseases.

Indexed as

Circadian ClocksInsulin ResistanceAnimalsARNTL Transcription FactorsDiet, High-FatGene DeletionGene Expression RegulationHumansLeptinLipid MetabolismMaleMiceMice, KnockoutNon-alcoholic Fatty Liver DiseaseObesityARNTL Transcription FactorsBMAL1 protein, humanLeptincircadian clockestrogengrowth hormoneinsulin resistancenonalcoholic fatty liver disease

Identifiers

PMID35238641
PMCPMC8916004
OpenAlexW4214820097

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.